ARS Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.571; its P/E ratio is -16.16; ARS Pharmaceuticals is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	$ 10.00K	$ 20.00K	$ 1.32M
Gross Profit	-	-	$ 10.00K	$ 20.00K	$ 1.32M
EBIT	$ -7.17M	$ -14.87M	$ -17.37M	$ -14.96M	$ 28.73M
EBITDA	$ -8.91M	-	$ -19.10M	$ -16.75M	$ 27.47M
Net Income Common Stockholders	$ -7.17M	$ -14.87M	$ -17.37M	$ -14.96M	$ 27.22M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 228.36M	$ 241.90M	$ 252.21M	$ 264.55M	$ 274.38M
Total Assets	$ 233.19M	$ 248.56M	$ 258.75M	$ 270.61M	$ 281.44M
Total Debt	$ 274.00K	$ 327.00K	$ 379.00K	$ 431.00K	$ 481.00K
Net Debt	$ -228.09M	$ -241.57M	$ -251.83M	$ -264.12M	$ -273.90M
Total Liabilities	$ 2.43M	$ 11.27M	$ 10.20M	$ 10.04M	$ 8.55M
Stockholders Equity	$ 230.76M	$ 237.28M	$ 248.55M	$ 261.15M	$ 272.89M
Cash Flow	-
Free Cash Flow	$ -17.31M	-	$ -16.70M	$ -12.62M	$ 11.88M
Operating Cash Flow	$ -17.41M	$ -12.76M	$ -16.67M	$ -12.43M	$ 11.40M
Investing Cash Flow	$ 26.04M	$ -46.64M	$ 44.97M	$ -111.55M	$ 485.00K
Financing Cash Flow	$ 1.80M	$ 921.00K	$ 2.85M	$ 1.32M	$ 189.39M

Currency in USD

ARS Pharmaceuticals Earnings and Revenue History

Income Statement >

ARS Pharmaceuticals Debt to Assets

Balance Sheet >

ARS Pharmaceuticals Cash Flow

Cash Flow >

ARS Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing